Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017). RLMD $35.0400 1.8100 % 5.4500 Relmada Therapeutics Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long […]
Read MoreAltus Power, Inc. (AMPS) Altus Power, Inc., a clean electrification company, originates, develops, owns, and operates roof, ground, and carport-based photovoltaic solar energy generation and storage systems. It serves commercial, industrial, public sector, and community solar customers. The company was founded in 2013 and is based in Stamford, Connecticut. CN Energy Group. Inc. (CNEY) N […]
Read MoreAxoGen, Inc. (AXGN) AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company’s products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site. AbbVie Inc. (ABBV) AbbVie Inc. […]
Read MoreBuy Price: $79.10 or better Sell Price: TradersPro Sell Signal General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. The stocks founds in the One Hot Stock category use stocks that are in long […]
Read MoreThe Technology sector was a bright spot throughout 2020 and 2021. It has also led the market lower throughout this year, with a lot of Tech stocks extending their own year-to-date losses well past traditional bear market levels. One of the reasons the sector led the market higher until 2022 is because so much of […]
Read More(Bloomberg) — The worst bond rout in decades is drawing more investors to government debt, with JPMorgan Asset Management joining the growing camp of bulls. Longer-dated sovereign notes in most developed markets are starting to look appealing given that yields are at levels last seen in 2010, according to Arjun Vij, a money manager at […]
Read More(Bloomberg) — After some of the most dramatic declines in global financial markets since the Federal Reserve began lifting borrowing costs six months ago, authorities in Asia are stepping up efforts to prevent a downward spiral. South Korea joined a growing list of interventions on Wednesday, with the central bank saying it will buy as […]
Read MoreAspen Technology, Inc. provides enterprise asset performance management, asset performance monitoring, and asset optimization solutions worldwide. The company’s solutions address complex environments where it is critical to optimize the asset design, operation, and maintenance lifecycle. AZPN $232.9900 11.5100 % 5.2000 Aspen Technology Sector : Computer and Technology Industry : Internet – Software Signal Short Term […]
Read MoreHealthEquity, Inc. (HQY) HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices. InnovAge Holding Corp. (INNV) InnovAge Holding Corp. manages and provides a range of medical and ancillary […]
Read MoreLas Vegas Sands Corp. (LVS) Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States. It owns and operates The Venetian Macao Resort Hotel, the Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Hotel Macao, Cotai Strip, etc. Rave Restaurant Group, Inc. […]
Read MoreBuy Price: $71.55 or better Sell Price: TradersPro Sell Signal HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices. The stocks founds in the One Hot Stock category use stocks […]
Read More2022 has meant a lot of uncertainty in the marketplace. Inflation, rising interest rates and war are just the biggest headlines that have kept the markets on edge, pushing the market into a confirmed bear market by June, and testing those lows as a new set of bearish momentum is picking up. While everybody wants […]
Read More(Bloomberg) — The US housing market took a turn in July. A national measure of prices rose 15.8% year-over-year, the S&P CoreLogic Case-Shiller index showed Tuesday. That was the smallest gain since April 2021, and the slowdown from the 18.1% jump in June was the largest deceleration in the history of the index, according to […]
Read More(Bloomberg) — Tens of thousands of solar panels are sitting unused in warehouses across Europe just as the continent struggles with an unprecedented energy crisis. The spike in electricity prices after Russia’s invasion of Ukraine is making the case for a speedier transition to renewable power. Demand for solar from households and businesses is soaring […]
Read MoreSatsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company’s lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate. STSA $6.8400 -0.4800 % -6.5600 Satsuma Pharmaceuticals Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend […]
Read More